Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Ratios & Valuation

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin36.3%+1.7pp35.9%+1.4pp35.6%+0.7pp35.3%-0.4pp34.5%-2.6pp
Operating margin20.3%+1.2pp19%-0.7pp19.5%-0.4pp19.6%-0.8pp19.1%-2.8pp
Net margin16.8%+0.7pp16.1%-1.0pp16.3%-1.1pp16.5%-1.8pp16.1%-3.3pp
EBITDA margin25.8%+1.2pp24.6%-0.5pp24.9%-0.1pp25.1%-0.3pp24.6%-2.1pp
Free cash flow margin14.2%+3.6pp15.3%+5.7pp12.6%+1.4pp11.6%-0.8pp10.6%-2.6pp
Returns
Return on equity19.1%+1.7pp16.9%-0.9pp16.9%-0.8pp17.7%-2.0pp17.4%-3.4pp
Return on assets14%+1.1pp12.5%-0.7pp12.6%-0.8pp13.1%-1.6pp12.9%-2.6pp
Return on invested capital19.2%+1.4pp17.9%-1.3pp17.6%-1.8pp17.8%-2.9pp17.8%-5.4pp
Efficiency
Asset turnover0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×
Inventory turnover4.9×+0.2×4.8×+0.1×4.6×+0.1×4.6×+0.3×4.6×+0.4×
Liquidity
Current ratio2.7×-0.1×3×+0.2×2.9×-0.1×2.8×+0.4×2.8×+0.2×
Quick ratio2×0.0×2.3×+0.2×2.2×0.0×2.1×+0.4×2×+0.1×
Cash ratio0.8×0.0×1.2×+0.3×1×0.0×0.8×+0.1×0.8×-0.2×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-0.2×-0.1×-0.6×-0.4×-0.4×-0.2×-0.3×-0.1×-0.1×+0.2×
Per Share
Book value per share$41.30+12.4%$43.69+20.0%$42.03+12.1%$40.40+15.6%$36.75+1.9%
Valuation
Market capitalization$18.07B+11.6%$19.79B-16.6%$18.86B-13.9%$16B-33.9%$16.18B-44.4%
Enterprise value$17.87B+11.1%$19.33B-17.9%$18.54B-14.7%$15.8B-34.4%$16.09B-44.1%
Price / earnings33.3×-1.4×40.1×-8.1×38.4×-5.5×32.8×-13.3×34.6×-16.5×
Price / sales5.6×0.0×6.4×-1.8×6.3×-1.4×5.4×-3.0×5.6×-4.3×
Price / book6×0.0×6.2×-2.6×6.2×-1.8×5.5×-3.9×6×-4.8×
EV / EBITDA21.5×-1.1×25.6×-6.9×24.6×-5.5×21.3×-11.7×22.6×-14.2×
EV / sales5.5×0.0×6.3×-1.8×6.1×-1.4×5.3×-3.0×5.6×-4.3×
Free cash flow yield2.5%+0.6pp2.4%+1.2pp2%+0.5pp2.2%+0.7pp1.9%+0.6pp
Earnings yield3%+0.1pp2.5%+0.4pp2.6%+0.3pp3%+0.9pp2.9%+0.9pp
Dividend yield0.3%0.0pp0.3%+0.1pp0.3%+0.1pp0.4%+0.1pp0.4%+0.2pp
PEG ratio2.1×—197.5×———————

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are West Pharmaceutical Services's profit margins?
West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.
Where do West Pharmaceutical Services's ratios come from?
Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.